Legend Biotech Corporation - stock earnings
LEGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -144.8 million USD | 79.5 million USD |
| 2023Q3 | -62.2 million USD | 96.0 million USD |
| 2023Q2 | -199.1 million USD | 73.3 million USD |
| 2023Q1 | -112.1 million USD | 36.3 million USD |
| 2022Q4 | -112.1 million USD | 36.3 million USD |
| 2022Q3 | -85.0 million USD | 27.4 million USD |
| 2022Q2 | -193.2 million USD | 12.0 million USD |
| 2022Q1 | -193.2 million USD | 12.0 million USD |
| 2021Q4 | -88.3 million USD | 39.0 million USD |
| 2021Q3 | -125.4 million USD | 16.9 million USD |
| 2021Q2 | -91.6 million USD | 20.2 million USD |
| 2021Q1 | -57.8 million USD | 40.8 million USD |
| 2020Q4 | -57.8 million USD | 40.8 million USD |
| 2020Q3 | -66.5 million USD | 11.7 million USD |
| 2020Q2 | -134.9 million USD | 11.6 million USD |
| 2020Q1 | -44.2 million USD | 11.5 million USD |
| 2019Q4 | -63.9 million USD | 19.5 million USD |
| 2019Q3 | -27.8 million USD | 17.7 million USD |
| 2019Q2 | -28.8 million USD | 10.1 million USD |
| 2019Q1 | -12.4 million USD | 10.1 million USD |
LEGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -518.3 million USD | 285.1 million USD |
| 2022 | -446.3 million USD | 117.0 million USD |
| 2021 | -386.2 million USD | 89.8 million USD |
| 2020 | -303.5 million USD | 75.7 million USD |
| 2019 | -133.0 million USD | 57.3 million USD |
| 2018 | -2.8 million USD | 49.1 million USD |
| 2017 | 9.4 million USD | 23.6 million USD |
LEGN
Price: $45.72
52 week price:
Earnings Per Share: -2.94 USD
P/E Ratio: -20.60
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 302700
Market Capitalization: 9.6 billion